Introduction {#Sec1}
============

Ageing is a complex multifactorial physiological process involving biochemical and morphological changes at the cellular level that are reflected throughout the organism. Several theories of ageing have emerged over the years, such as mitochondrial dysfunction, accumulation of DNA and oxidative damage, an increase in protein aggregates, as underlying the ageing process. One of the features of ageing and even healthy ageing is a gradual and inevitable loss of skeletal muscle mass and force, sarcopenia, a condition that can significantly impact the quality of life in older adulthood by increasing frailty and potentially reducing independence.

The decline in muscle mass and function in older people appears primarily due to loss of muscle fibres with weakening of the remaining fibres (Marzetti et al. [@CR93]). Moreover, data clearly indicate that in rodents and humans, loss of motor neurons accompanies the loss of muscle fibres (Brown et al. [@CR14]; Butikofer et al. [@CR17]; Campbell et al. [@CR20]; Einsiedel and Luff [@CR42]; Hettwer et al. [@CR61]; Larsson and Ansved [@CR84]; Lexell et al. [@CR87], [@CR88]; Sakellariou et al. [@CR132]; Valdez et al. [@CR159]). In humans, Ling et al. have shown that ageing is associated with an increase in motor unit size but a decline in motor unit firing rate in humans (Ling et al. [@CR90]). These data suggest that altered motor unit activation occurs after sarcopenia development (Ling et al. [@CR90]). A study by Piasecki et al. has demonstrated that neuromuscular ageing is associated with loss of motor units and instability of neuromuscular junction (NMJ) transmission in humans however, the loss of motor axons and changes to motor unit potential transmission occur before a clinically relevant loss of muscle mass and function (Piasecki et al. [@CR121]). Whether the changes in the anatomy and function of the NMJ with age play a casual role in sarcopenia development or are a part of the compensatory mechanism aiming at preserving neuromuscular function, remains to be established.

Several studies (Adinolfi et al. [@CR1]; Grover-Johnson and Spencer [@CR55]; Sharma et al. [@CR139]; Verdu et al. [@CR164]) have also shown that neuronal changes and changes at the NMJ play a major role in the age-related loss of muscle mass and function (Delbono [@CR34]). Interestingly, examination of the effects of ageing in peripheral nerves does not reveal an increase in gross oxidative damage similar to the muscle they innervate, but does show an altered redox environment with age (McDonagh et al. [@CR102]). Regeneration of adult skeletal muscle is largely dependent on satellite cells, the skeletal muscle stem cells (Mauro [@CR95]; McCarthy et al. [@CR99]; Morgan and Partridge [@CR105]). The regeneration of skeletal muscle is also reported to be disrupted during ageing (Sousa-Victor et al. [@CR147]) and age-related changes in satellite cell number, their increased susceptibility to apoptosis and impaired ability to proliferate, have been reported in old humans and rodents (Bernet et al. [@CR8]; Brack and Rando [@CR11]; Carlson et al. [@CR21]; Charge and Rudnicki [@CR23]; Collins et al. [@CR31]; Jejurikar et al. [@CR67]; Kadi et al. [@CR71]; Shefer et al. [@CR140]; Snijders et al. [@CR142]; Verdijk et al. [@CR163]). The involvement of satellite cells in age-related muscle wasting remains to be established, as recent data indicate that satellite cell dysfunction may not be a key factor contributing to sarcopenia development (Fry et al. [@CR47]). The main physiological and genetic changes associated with age-related sarcopenia are summarised in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Schematic representation of age-related changes in skeletal muscle and genetic and epigenetic mechanisms associated with these changes

The disrupted balance between muscle hypertrophy and atrophy, degeneration of NMJ and dysfunction of satellite cells, have all been associated with sarcopenia development. This review discusses the mechanisms regulating disrupted muscle homoeostasis during ageing, focusing on---redox homoeostasis and DNA damage responses, including recent novel developments concerning microRNAs and circadian regulation of gene expression in skeletal muscle and how manipulating these processes could potentially provide a therapeutic opportunity to prevent age-associated sarcopenia.

Redox associated mechanisms in skeletal muscle ageing {#Sec2}
=====================================================

Redox homoeostasis in skeletal muscle {#Sec3}
-------------------------------------

Regular exercise is increasingly used as a therapeutic strategy to prevent age-related muscular atrophy as well as a number of age-related diseases, including metabolic disorders such as Type 2 diabetes. It is noteworthy that the benefits of exercise may not be equal between young and older people, partially due to the blunted adaptive responses of skeletal muscle in older people (Drummond et al. [@CR37]) (Table [1](#Tab1){ref-type="table"}). Table 1Key transcription factors associated with maintenance of healthy skeletal muscle and age-associated muscle phenotypesTranscription factorRole in muscleAge-related changesReferencesAP-1Regulator of PGC-1α, interacts with NF-kB and MMP2Impaired activation with ageBaresic et al. ([@CR201]), Hollander et al. ([@CR207]), Liu et al. ([@CR210]) and Vasilaki et al. ([@CR162])BMAL/CLOCKGlucose uptake and oxidation, sarcomeric organisation and fibre-type switching, mitochondrial volume and respirationDampened gene expression with ageAndrews et al. ([@CR3]) and Dyar et al. ([@CR38])FOXO1, 3 & 4Key mediators of catabolic response during atrophyDecreased activity with ageFuruyama et al. ([@CR204]), Milan et al. ([@CR211]), Pardo et al. ([@CR214]) and Sandri et al. ([@CR218])HSF-1Regulates molecular chaperonesImpaired activation with ageBaird et al. ([@CR200]) and Vasilaki et al. ([@CR221]b)MyoDRegulator of muscle-specific target genes involved in myogenic differentiationExpression upregulated during ageingDedkov et al. ([@CR203])NFκBRole in muscle atrophy during fastingConstitutively active in old and dysregulated activation after exerciseLee and Goldberg ([@CR209]) and Vasilaki et al. ([@CR162])Nrf2Master regulator of antioxidant proteinsImpaired activity and contributes to muscle atrophy, muscle progenitor functionMiller et al. ([@CR212]), Safdar et al. ([@CR216]) and Narasimhan et al. ([@CR213])Myostatin (GDF8); Smad2/3Regulation of muscle hypertrophyNot clear due to complex post-translational modificationsSartori et al. ([@CR219]) and White and LeBrasseur ([@CR222])TFAMMaintenance and organisation of mtDNAImpairment of pathway with age, closely related to activityBori et al. ([@CR202]), Larsson et al. ([@CR208]) and Picca et al. ([@CR215])TFEBCoordinates expression of autophagic and lysosomal genesKey regulator of autophagy and modulation of longevityLapierre et al. ([@CR83], [@CR83])REV-ERBα (NR1D1)Mitochondrial biogenesis, autophagy and exercise toleranceNot investigatedWoldt et al. ([@CR171])

The metabolic and structural changes induced by exercise ultimately affect the contractile properties of the muscle fibres and as contracting muscles generate ROS/RNS, these signalling molecules play crucial roles in the adaptive response to exercise and muscle atrophy during ageing (Table [2](#Tab2){ref-type="table"}, Powers and Jackson [@CR123]). ROS/RNS generate unique signalling cascades that are essential in skeletal muscle contraction and adaptation, but also play a role in a wide array of cell processes including cell proliferation, immune response and antioxidant defences. The age and fitness of the individual as well as the intensity and duration of muscle contractions will have an effect on both the levels and type of ROS/RNS generated. Dysregulated ROS/RNS homoeostasis or signalling responses have been reported in a wide variety of human skeletal muscle disorders, as well as many metabolic diseases including cancers (Mates et al. [@CR94]), neurodegeneration (Calabrese et al. [@CR19]), obesity (O'Neill et al. [@CR114]) and diabetes (Gil-del Valle et al. [@CR51]). Key proteins and transcription factors activated in response to muscle contraction can be directly or indirectly regulated by the concentrations of ROS/RNS e.g. NFκB (Ji et al. [@CR69]), sarcoplasmic--endoplasmic reticulum Ca^2+^ ATPase (SERCA) (Tong et al. [@CR156]) and ryanodine receptor 1 (RyR1) (Sun et al. [@CR153]).Table 2Selected redox homoeostasis processes associated with exercise and ageing proposed to play an important role in muscle homoeostasisProcessAgeing-associated consequencesProposed mechanismMuscle contractionIncreased oxidation of contractile proteins; disrupted fatty acid oxidation due to accumulation of dysfunctional mitochondriaChanges in mitochondrial activity (Gerhart-Hines et al. [@CR206]; Carnio et al. [@CR22])Disrupted autophagy resulting in defective regeneration and myofibre atrophyActivation of autophagy (Sandri [@CR217]; Tang and Rando [@CR220]; Garcia-Prat et al. [@CR205])Neuromuscular functionDisrupted redox balance resulting in myofibre atrophy, NMJ degenerationSOD1 activity (Sakellariou et al. [@CR132])Satellite cell functionDisrupted protection against excessive ROS and DNA damage resulting in disrupted quiescence of satellite cells and their niche resulting in defective regenerationActivity of antioxidant enzymes (Pallafacchina et al. [@CR115])SenescenceOxidative stress and deterioration in muscle regeneration satellite cell senescenceROS production in satellite cells (Garcia-Prat et al. [@CR205])

Sources of ROS/RNS in skeletal muscle {#Sec4}
-------------------------------------

There are a number of potential endogenous sources of ROS/RNS in skeletal muscle. Recent studies indicate that cytoplasmic generation, rather than electron leakage from the electron transport chain, are primarily responsible for the increase in ROS/RNS generation within healthy skeletal muscle following contractions (Pearson et al. [@CR119]; Sakellariou et al. [@CR131], [@CR133]; Ward et al. [@CR169]). As ROS/RNS are too reactive to produce a signalling effect by diffusion throughout the cell, it is now considered that they produce an effect localised to their site of generation (Poole [@CR122]). In relation to skeletal muscle, two known endogenous producers of ROS/RNS are the NAD(P)H oxidase (NOX) family and nitric oxide synthases (NOS) and they predominantly generate superoxide (O~2~^·−^) and nitric oxide (NO), respectively. Isoforms of both these proteins are in an ideal position to control redox mechanisms in muscle as they are known to co-localise within the T-tubule (Stamler and Meissner [@CR149]; Ward et al. [@CR169]). Neuronal and endothelial NOS (nNOS and eNOS) contain a calmodulin binding site making them sensitive to Ca^2+^ release and muscle contractions (Stamler and Meissner [@CR149]). Indeed NO and O~2~^·−^ produced by NOS and NOX may react and form another redox oxidant, peroxynitrite (ONOO^−^), these species of ROS/RNS have different chemical reactivities and kinetics, resulting in distinct post-translational modifications on target proteins with potentially further downstream redox effects. Ageing itself could result in different species and concentrations of ROS/RNS generated as a result of muscle contractions. This could potentially have a significant effect on downstream protein targets and their activity with further far reaching effects on the molecular responses to exercise.

Redox regulation of transcription factors in skeletal muscle {#Sec5}
------------------------------------------------------------

Skeletal muscle can respond rapidly to exercise and other environmental changes by modifying the expression of genes involved in the regulation of muscle structure, mass and energy metabolism. The ROS/RNS generated during contractile activity have been reported to lead to the activation of a number of redox-regulated transcription factors, including NFκB, AP-1, HSF-1 and NRF2 (Table [1](#Tab1){ref-type="table"}) with a subsequent increased expression of regulatory enzymes in both pro- and anti-inflammatory processes depending on the level of ROS/RNS generated and the transcription factor activated (Ji et al. [@CR69]; Vasilaki et al. [@CR161]a). For instance, it has been shown that NFκB is constitutively activated in muscle tissue from old mice while in adult mice it is activated only after intense muscle stimulation (Vasilaki et al. [@CR162]).

Redox-regulated processes coupled with muscle contractions are reported to stimulate the expression of genes associated with autophagy and cellular longevity, especially the regulation of the helix-loop-helix transcription factor TFEB and the forkhead (FOXO) transcription factors (reviewed in Lapierre et al. [@CR83]). TFEB regulates the transcription of genes involved in autophagic induction, phagophore formation and degradation, while its phosphorylation is mTOR dependent and prevents its translocation to the nucleus (Settembre et al. [@CR138]). FOXO transcription factors also regulate many of the genes involved in the autophagy core machinery, glucose metabolism, the antioxidant response and can directly interact with AMPK, thus the activation of these transcription factors is highly dependent on the nutrient-sensing pathways and energy availability. Changes in ROS/RNS generation and subsequently redox signalling have an effect on a wide variety of cellular control points including, hypoxia-inducible factor 1α (HIF-1α), activator protein 1 complex (AP-1), NFκB, the sirtuin deacetylase enzymes, mitochondrial biogenesis and can have a wide-ranging influence on the cellular energy flux. A number of recent studies have linked the redox state of the thiol peroxidases peroxiredoxins (Prxs) and H~2~O~2~ signalling to the activation of specific cellular pathways e.g. Prx1 activation of the transcription factor Ask1 (Jarvis et al. [@CR66]) and Prx2 forms a redox relay with the transcription factor STAT3, generating oligomers with modified transcriptional activity (Sobotta et al. [@CR144]). Similarly, the FOXO3 transcription factor has been shown to require the formation of intermolecular disulphides with the nuclear receptors, importin 7 and 8, for ROS-induced nuclear translocation and activity (Putker et al. [@CR125]). Redox signalling mediated by disulphide exchange on redox-sensitive proteins and receptors at physiologically relevant concentrations of H~2~O~2~, would allow rapid activation and/or translocation to the nucleus of transcription factors in muscle fibres in response to contractile activity.

Altered redox homoeostasis and skeletal muscle ageing {#Sec6}
-----------------------------------------------------

Ageing muscle has as an altered redox response with subsequent physiological and biochemical effects on the cytoskeleton, mitochondria, calcium signalling and sequestration (Egan and Zierath [@CR41]; Labunskyy and Gladyshev [@CR80]; McDonagh et al. [@CR101]). Older individuals that have maintained an exercise regime throughout their lifetime have been reported to have preserved biochemical markers of muscle fitness \[mtDNA, peroxisome proliferator-activated receptor coactivator 1α (PGC-1α)\] that are comparable to younger individuals (Cobley et al. [@CR30]). A recent study highlighted the plasticity of skeletal muscle by reversing the biochemical effects of ageing with NAD^+^ treatment (Gomes et al. [@CR53]). Acute bouts of strenuous exercise however, can result in muscle damage that contrasts to the adaptive improvement that is achieved from exercise as a therapeutic agent (Aoi et al. [@CR4]). Muscle damaging effects of strenuous exercise can result in a dysregulated redox response within the muscle compared with the adaptive responses and benefits of a transient increase in ROS/RNS. It is also worth mentioning that although exercise ameliorates, it does not prevent the progressive loss of muscle strength that occurs in the elderly, suggesting that blunted adaptive responses to exercise, potentially through redox-mediated mechanisms, occur with ageing.

Acute exercise induces autophagy in both skeletal and cardiac muscle (He et al. [@CR60]). In relatively long-lived skeletal muscle fibres the adaptive response to exercise requires the degradation of cellular components, allowing the muscle fibre to rebuild and respond to repetitive bouts of exercise. Interestingly, myofibrillar components of muscle are mainly degraded by the ubiquitin--proteasome system while dysfunctional organelles and protein aggregates are degraded through autophagy. Autophagy is a key house-keeping mechanism where the interplay between autophagy and cellular damage is finely balanced and can be the difference between beneficial adaptation, cell death or accumulation of damaged cellular organelles (He et al. [@CR60]). Indeed, excessive autophagy can be detrimental in skeletal muscle resulting in muscle wasting and has been reported in a number of cancers, cachexia and dystrophies (Vainshtein et al. [@CR158]). Reduced mitochondrial turnover and decreased autophagy have been associated with a number of chronic conditions, including ageing in skeletal muscle, with increased myosin and actin oxidation resulting in decreased force due to reduced sliding properties in the fibre (Romanello and Sandri [@CR130]). Recent studies have demonstrated that inhibition of autophagy can increase mitochondrial damage not only within the muscle but also in the NMJ and to ultimately affect animal lifespan (Carnio et al. [@CR22]). Accumulation of damaged or dysfunctional mitochondria has been demonstrated to increase the oxidation of contractile proteins in muscle whilst enhancing autophagy can contribute to longevity (Carnio et al. [@CR22]), with potentially important consequences in the elderly for the maintenance of muscle mass and function. Acute exercise can cause rapid changes in mRNA levels within a cell but changes in protein content generally occur over a relatively longer period.

DNA damage and skeletal muscle {#Sec7}
==============================

Markers of DNA damage {#Sec8}
---------------------

As with all theories concerning the mechanism of skeletal muscle ageing, it is difficult to definitively assign a causal role to DNA damage and repair in the process. However, without doubt, DNA damage has the potential to be deleterious either as a direct consequence of the DNA damage itself or as a downstream effect of the DNA repair processes. Not surprisingly perhaps, excessive ROS/RNS generation is the primary source of DNA damage in skeletal muscle. There are numerous DNA lesions that can occur as a consequence of the excessive generation of ROS/RNS including abasic sites, strand breaks and \>100 base modifications, which if unrepaired, lead to mutations and genomic instability, especially in replicating DNA such as mtDNA, that play essential roles in ageing.

Of the four nucleotides, guanine has the lowest oxidation potential and is therefore most vulnerable to oxidative modifications (Steenken and Jovanovic [@CR150]). The most abundant, and most frequently studied base modification is 8-oxo-7,8-dihydroguanine (8-oxoG), which can result from direct attack on the DNA or incorporation of an oxidised base from the nucleotide pool. 8-oxoG has the potential to be mutagenic because it can adopt the *syn* configuration and during DNA replication forming a Hoogsteen pair with adenine (in the *anti*-configuration) resulting in a G:C to T:A transversion mutation (Cheng et al. [@CR25]). Particularly relevant is the observation that 8-oxoG may affect transcription factor binding in G4-rich promoters e.g. binding of Sp1 (Clark et al. [@CR29]), which has been shown to promote myoblast differentiation (Yuan et al. [@CR174]) and the expression of the anti-inflammatory NFκB p50 subunit (Hailer-Morrison et al. [@CR56]). 8-oxoG can also block transcription elongation via RNA polymerase II (Kuraoka et al. [@CR79]) or result in the production of mutant transcripts (Bregeon et al. [@CR12]). There are only a few studies of 8-nitrodG primarily because it is unstable. However, a recent study (Bhamra et al. [@CR9]) has provided evidence that 8-nitrodG has the potential to not only mispair with adenine leading from G:C to T:A transversion mutations, but may also stall replication forks resulting in single strand breaks (SSBs) and gaps which can convert to double strand breaks (DSB). 8-oxoG may also lead to increased DNA damage such as further oxidation products (Morikawa et al. [@CR106]) and the development of SSBs via the base excision repair (BER) pathways which can either remove the 8-oxoG (Caglayan and Wilson [@CR18]) or remove the mispaired adenine (Sheng et al. [@CR141]). In addition to the effects of BER, SSBs can also be created via direct ROS attack on DNA. Furthermore, if two SSBs are close together or they occur in DNA which is being replicated e.g. mtDNA or proliferating satellite cells, the SSBs can be converted into DSBs which are lethal if not repaired (O'Driscoll and Jeggo [@CR110]). Interestingly, elevated levels of 8-oxoG were detected in the *Vastus lateralis* of aged individuals compared to young subjects potentially linking nDNA damage and skeletal muscle dysfunction (Radak et al. [@CR126]). Interestingly, the levels of 8-oxoG in old sedentary subjects were higher compared to old active subjects, indicating that physical activity may confer a genoprotective effect.

DNA damage and skeletal muscle {#Sec9}
------------------------------

The cell fate following DNA damage---DNA repair, cell cycle arrest, apoptosis, senescence or necroptosis (Gebel et al. [@CR48]; Vicencio et al. [@CR165]), is dependent on a range of factors including the cell type e.g. satellite cells, muscle fibres or motor neurons, the type, extent, site (e.g. regulatory v coding; nuclear v mitochondrial), and time of the DNA damage and the health, age and exercise status of the individual. Skeletal muscle satellite cells are key components required for muscle repair following muscle injury. The normally quiescent satellite cells are stimulated to enter the cell cycle following damage to the muscle. Following activation, there is either commitment of the progeny to the production of myoblasts, which then fuse with the muscle fibre, or there is self-renewal of the satellite cells in their niche. It is therefore essential that the genome integrity of satellite cells is maintained either by protection from DNA damage, removal of damaged cells and/or enhanced repair. All of these processes appear to be involved in preventing genomic instability in stem cells but with age these processes begin to fail, leading to genome-wide accumulation of passenger mutations, reduced replicative capacity and altered progenitor cells, ultimately resulting in defective tissue maintenance (Burkhalter et al. [@CR16]). Satellite cells have high transcript levels for genes involved in the protection against excessive ROS (Pallafacchina et al. [@CR115]) and their niche helps protect them from oxidative stress-induced damage. Satellite cells are also able to repair DSBs more efficiently than their differentiated progeny, myoblasts and differentiated myonuclei (Vahidi Ferdousi et al. [@CR157]). The ability of satellite cells to regenerate declines with age and although there may be a slight reduction in repair capacity, there does not seem to be any obvious age-related difference in the accumulation of DNA damage especially DSBs (Cousin et al. [@CR32]). Proliferating muscle stem cells appear to have more DSBs than satellite cells but unlike satellite cells they use both c-NHEJ and HRR to repair these breaks (Vahidi Ferdousi et al. [@CR157]). Myoblasts also have higher levels of poly-ADP-ribose-polymerase 1 (PARP1) compared to differentiated cells which correlates with an increase in resistance to oxidative stress in the myotubes (Olah et al. [@CR111]).

There is considerable evidence linking DNA damage (in mitochondrial and nuclear genomes) and defects in DNA repair mechanisms to neurodegenerative diseases (Iyama and Wilson [@CR65]), although there have been few studies on the effects of DNA damage on the viability of motor neurones. However, a recent study (Chu et al. [@CR28]) has demonstrated that H~2~O~2~ causes a downregulation of APE1 (a key BER protein required for the repair of 8-oxoG and abasic sites in both nuclear and mtDNA in spinal motor neurons). In addition, because APE1 is also a redox responsive protein, this downregulation increased the sensitivity of the motor neurons to oxidative stress and likelihood of cell death. Further studies are required to investigate the role(s) of oxidative stress-induced DNA damage and downregulation of APE1 in motor neurons in muscle ageing.

There is also growing evidence linking the protective effects of exercise against DNA damage and increase in repair mechanisms during ageing. However, the consequences of damage and repair may be more complex than mutations affecting genomic stability or cell fates such as apoptosis, and more work is required to understand their relevance to muscle ageing.

Post-transcriptional regulation of age-related muscle loss in skeletal muscle {#Sec10}
=============================================================================

MicroRNAs and skeletal muscle ageing {#Sec11}
------------------------------------

MicroRNAs (miRNAs, miRs) are short, non-coding RNAs that regulate gene expression at the post-transcriptional level, they are implicated in many biological processes, including muscle function and disease (Goljanek-Whysall et al. [@CR52]). miRNAs are predicted to target two-thirds of the human genome (Friedman et al. [@CR46]), affecting the mRNA and protein content while providing a robust mechanism of responding to changes within the cell or the surrounding environment. Muscle-specific miRNAs are crucial regulators of skeletal muscle function (Brown and Goljanek-Whysall [@CR13]; Goljanek-Whysall et al. [@CR52]; Soriano-Arroquia et al. [@CR145]) and differential expression of miRNAs are associated with muscle disorders, such as muscular dystrophy (Eisenberg et al. [@CR43]; Elia et al. [@CR44]; Soares et al. [@CR143]; Williams et al. [@CR170]). The ability of miRNAs to target many genes regulating specific physiological processes, their conservation among species, as well as the ability of manipulating the expression of miRNAs in vitro and in vivo, has contributed to the growing interest in miRNAs as potential therapeutic agents. Although the involvement of specific miRNAs in the development of sarcopenia remains unclear, key physiological processes affected by ageing including both hypertrophy and atrophy, as well as muscle regeneration, are regulated by miRNAs, and likely important regulators of age-related decline in muscle mass and function.

Skeletal muscle senescence has also been shown to be regulated by miR-29. miR-29 expression is upregulated in skeletal muscle of mice during ageing. miR-29 has been shown to regulate the expression of p85alpha, IGF-1 and B-myb (Hu et al. [@CR64]). Upregulation of miR-29 expression was associated with impaired proliferation of muscle progenitor cells and their senescence. Moreover, miR-29 overexpression in vivo, in muscles of adult mice, led to a senescent phenotype of muscle and muscle atrophy (Hu et al. [@CR64]).

Satellite cell-specific knock out of the enzyme Dicer leads to defective muscle regeneration and premature muscle wasting suggesting that miRNAs may play a pivotal role in maintaining satellite cell potential in adulthood (Cheung et al. [@CR27]). Our work has shown that miR-143 may be associated with, at least to some degree, controlling satellite cell senescence via regulating the expression of IGFBP5 (insulin growth factor-binding protein 5) (Soriano-Arroquia et al. [@CR146]). Interestingly, age-related changes in miR-143 expression in satellite cells appear to be a part of a compensatory mechanisms aiming at ameliorating age-related changes in satellite cell function rather than a causative mechanisms responsible for these changes; this keeps in with previously published role of miRNA-206 in ALS (Williams et al. [@CR170]).

MicroRNAs and the neuromuscular junction {#Sec12}
----------------------------------------

NMJ deterioration is an important physiological aspect of ageing associated with muscle atrophy. NMJ formation is regulated by miRNAs---mice deficient of Dicer, an enzyme required for the maturation of most miRNAs, show impaired reinnervation following nerve injury (Valdez et al. [@CR160]). Using the amyotrophic lateral sclerosis (ALS) mouse model, characterised by deterioration of NMJs and muscle atrophy, Williams et al. have demonstrated that muscle-enriched miR-206 (myomiR) is a key regulator of muscle--nerve interactions and is required for efficient regeneration of NMJ after nerve injury by regulating *Hdac4* (Williams et al. [@CR170]). Interestingly, another myomiR, miR-133b, expression of which is concentrated near NMJs and induced following denervation, has been shown not to play a role in NMJ maintenance and reinnervation (Valdez et al. [@CR160]) suggesting that miR-206 may be the key regulator of NMJ deterioration.

Redox homoeostasis and microRNAs {#Sec13}
--------------------------------

One of the key mechanisms associated with muscle ageing is disrupted redox homoeostasis (Gianni et al. [@CR50]). miRNAs may be linked to the redox status of the muscle through post-transcriptional regulation of key enzymes involved in ROS/RNS signalling (Togliatto et al. [@CR155]). Overexpression of miR-106b led to mitochondrial dysfunction and insulin resistance in C2C12 myotubes by targeting the expression of mitofusin-2 (Mfn2), as well as PGC-1α (Zhang et al. [@CR178]). Interestingly, ROS signalling has also been shown to regulate not only the expression of miRNAs controlling important aspects of skeletal muscle homoeostasis, but also miRNA function through modifications of the mature microRNAs (Wang et al. [@CR168]). Oxidative modification of mature miR-184 has been shown to modify miRNA:target interactions. Wang et al. have demonstrated that oxidative modification of miR-184 is associated with miR-184 targeting its non-native targets: Bcl-xL and Bcl-w, effectively leading to apoptosis initiation. As redox homoeostasis is disrupted in muscle during ageing and considering the rather long half-life of a vast number of miRNAs (Olejniczak et al. [@CR112]), oxidative modification of miRNAs could affect interactions with their target genes and be one of the mechanisms associated with age-related loss of muscle mass and function.

DNA damage itself has also been shown to modulate miRNA processing and maturation therefore affecting miRNA:target interactions (Hu and Gatti [@CR63]). The expression of several miRNAs associated with controlling muscle and satellite cell function (Cheung et al. [@CR27]; Soriano-Arroquia et al. [@CR146]) e.g. miR-16, miR-143, are upregulated following irradiation-induced DNA damage through a p53-dependent modification of the Drosha/DGCR8 complex associated with miRNA maturation (Suzuki et al. [@CR154]). Another study by Boominathan [@CR10] has demonstrated the regulation of miRNA processing by DNA damage response factors, through controlling of miRNA processing machinery (Boominathan [@CR10]). miRNAs are also emerging as a novel regulatory layer of DNA damage response (DDR) regulation (Hu and Gatti [@CR63]). For example, miR-24 has been shown to downregulate the expression of histone variant γH2AX, the sensor of the double strand break in DDR (Lal et al. [@CR82]), whereas miR-21, has been shown to participate in the DDR by controlling the expression of CDC25a, a cell cycle regulator (Wang et al. [@CR166]). Interestingly, miR-21 has also been shown to drive the fibrosis of skeletal muscle (Ardite et al. [@CR5]).

Exercise, the only current effective intervention against muscle wasting, has also been associated with changes in miRNA expression in skeletal muscle. For example, Nielsen et al. ([@CR109]) have shown that miR-206, miR-133 (myomiRs) expression is modulated following acute and endurance exercise in humans and myomiR levels decrease to a new steady-state level following an inactivity period (Nielsen et al. [@CR109]). Moreover, an acute bout of resistance exercise has been shown to be associated with downregulation of miR-1 in human muscle (McCarthy and Esser [@CR97]), suggesting that changes in miRNA expression may be an important mechanism associated with muscle adaptive responses. Comparison of miRNA expression in the skeletal muscle from young and old men before and after acute resistance exercise, revealed that changes in miRNA responses following exercise were absent in the older group, suggesting the involvement of miRNAs in regulating skeletal muscle adaptive response to contractions, which is defective in the muscles of older people (Rivas et al. [@CR129]).

Together, these data indicate that miRNA regulation is an integral part of skeletal muscle ageing. Understanding the disrupted miRNA:target interactions in sarcopenia development may provide novel therapeutic avenues against age-related loss of muscle mass and function.

Circadian regulation in skeletal muscle {#Sec14}
=======================================

Circadian rhythms and the molecular clock {#Sec15}
-----------------------------------------

Circadian rhythms are the \~24 h biological cycles in physiology, behaviour and metabolism that function to temporally organise and prepare an organism for daily environmental changes (Hastings et al. [@CR59]; Reppert and Weaver [@CR128]). They are highly evolutionarily conserved from single-cell organisms to mammals (Loudon [@CR92]). In mammals, the circadian pacemaker lies in the suprachiasmatic nucleus (SCN), located in the anterior hypothalamus, and is referred to as the central clock (Dibner et al. [@CR36]). It is entrained by light/dark cycles and it imposes synchronicity to peripheral organs such as skeletal muscle (Yamazaki et al. [@CR173]). Recent studies have pointed out the importance of autonomous peripheral clocks existing in every tissue, which respond to external cues (called 'Zeitgebers'), such as feeding or exercise, and therefore function in the environmental adaptation of organisms (Schroeder et al. [@CR136]; Wolff and Esser [@CR172]). In skeletal muscle, \>800 genes are expressed in a circadian pattern (Schroder and Esser [@CR134]), and these genes participate in a wide range of functions including myogenesis, transcription and metabolism (McCarthy et al. [@CR98]; Miller et al. [@CR104]).

The circadian oscillations in physiology and metabolism are governed by the molecular clock, a transcriptional/translational feedback mechanism that is present in virtually all cells of an organism (Ko and Takahashi [@CR74]). In mammals, the molecular clock components comprising the positive arm of the core clock are two members of the PAS-bHLH family of transcription factors, CLOCK (Circadian locomotor output control kaput) and BMAL1 (Brain muscle arnt-like1). The CLOCK:BMAL1 heterodimer activates transcription of core clock genes *Period* (*Per1*, *Per2* and *Per3*) and *Cryptochrome* (*Cry1* and *Cry2*) by binding to E-box (CACGTG) sequences in the regulatory region of these genes. The CRY and PER proteins constitute the negative arm of the core molecular clock by forming multimers that inhibit CLOCK:BMAL1 transcriptional activity upon translocation to the nucleus. Additional components to the core molecular clock family include the orphan nuclear receptors RORA (RAR-related orphan receptor-α) and REV-ERB α/β (NR1D1/2), which function by activating (ROR) or repressing (REV-ERB) *Bmal1* transcription. In addition to their role in timekeeping, components of the core clock such as BMAL1 and CLOCK have also been shown to transcriptionally regulate the expression of genes that do not function in timekeeping and these genes are designated as clock-controlled genes (CCGs) (Gossan et al. [@CR54]; Panda et al. [@CR116]). Some of the direct CCGs in specific tissues, such as skeletal muscle, often encode transcription factors/co-activators (MyoD1, PGC1α) (Andrews et al. [@CR3]; Liu et al. [@CR91]; Zhang et al. [@CR177]), genes that control rate-limiting steps in cell physiology or genes regulating specific muscle functions such as contractility, genes involved in calcium handling, metabolism (e.g. ATP synthases) (McCarthy et al. [@CR98]) and cell signalling (e.g. Wnt) (Chatterjee et al. [@CR24]; Burke et al. [@CR15]).

Post-transcriptional regulation of the molecular clock {#Sec16}
------------------------------------------------------

Emerging evidence indicates an important role for modulation of the molecular clock by the post-transcriptional regulation, from splicing, polyadenylation and mRNA stability to translation and non-coding functions exemplified by miRNAs (Kojima et al. [@CR75]; Staiger and Green [@CR148]). This level of regulation affects all aspects of the circadian system, from the core timing mechanism and input pathways that synchronise clocks to the environment and output pathways that control overt rhythmicity, thus enhancing robustness as well as the ability to adapt to different environments (Hansen et al. [@CR57]; Kojima et al. [@CR75]). Recent studies indicate a special role for miR-132 and miR-219 in mediating entrainment of the circadian clock in mice (Alvarez-Saavedra et al. [@CR2]; Cheng et al. [@CR26]). These miRNAs are regulated by the circadian and light-induced transcription factor CREB. miR-219, which is directly regulated by the CLOCK:BMAL1 heterodimer, affects the circadian pacemaker. In contrast, miR-132, appears independent of CLOCK:BMAL1, but displays circadian oscillations in the SCN that are dependent on the negative clock regulators CRY1 and CRY2. Moreover, miR-132 can also modulate the negative arm of the circadian clock as well as the responses of the molecular clock machinery to light. In addition to miRNAs, the timing of the molecular clock can be modulated by post-translational mechanisms through phosphorylation, acetylation and/or ubiquitination pathways (Lee et al. [@CR85]; Li et al. [@CR89]). These modifications impact the stability and/or translocation of core molecular clock components and often affect the periodicity of oscillations. Further work is needed to decipher the role of post-transcriptional mechanisms and miRNAs in peripheral tissue clocks such as skeletal muscle.

Models of circadian clock disruption and skeletal muscle ageing {#Sec17}
---------------------------------------------------------------

The importance of circadian rhythms for skeletal muscle is evidenced by the skeletal muscle phenotypes observed in mouse models of genetic clock disruption (reviewed in Mayeuf-Louchart et al. [@CR96]). Global loss of the core clock gene *Bmal1* results in accelerated sarcopenic phenotypes, including severe muscle degeneration (reduced total mass), fibre-type shifts, decreased mitochondrial volume and respiration (with increased respiratory uncoupling), altered sarcomeric structure and reduced force production at both the whole-muscle and single-fibre level (Kondratov et al. [@CR76]; Andrews et al. [@CR3]; Dyar et al. [@CR38]). Moreover, another model of genetic disruption of the positive arm of the clock, *Clock*^*Δ19*^ mutant mice, display a reduction in skeletal muscle force and decreased exercise tolerance, which is associated with decreased mitochondrial content/activity and perturbations of muscle architecture involving decreased expression of structural proteins (Hodge et al. [@CR62]; Jeong et al. [@CR68]; Kondratov et al. [@CR76]). However, these perturbations do not affect the adaptation of *Clock*^*Δ19*^ mice to chronic exercise (Pastore and Hood [@CR117]). In addition, *Bmal1*^*KO*^ mice show detrimental effects on metabolic health, including impaired glucose tolerance and insulin sensitivity (Kondratov et al. [@CR76]). Mice mutated for *Per2*, a component of the negative arm of the core clock, also have lower running endurance and locomotor performances due to an increased reliance on glycolytic anaerobic metabolism rather than an alteration of muscle contractility (Bae et al. [@CR6]; Zheng et al. [@CR179]). Recent work has also demonstrated that *Rev*-*erbα* deficiency (a component of the stabilising loop) results in lower exercise capacities, due to impaired mitochondrial biogenesis and an increase in autophagy in skeletal muscle (Woldt et al. [@CR171]). Rescuing the expression of *Bmal1* specifically in the skeletal muscle of global *Bmal1*^*KO*^ mice, although it did not improve locomotor rhythmicity, it restored normal levels of activity and body weight as well as longevity (McDearmon et al. [@CR100]) suggesting an important role of muscle-specific *Bmal1* in skeletal muscle maintenance and ageing. In contrast to whole-body *Bmal1*^*KO*^ mice, locomotor activity was normal and there was no sign of sarcomere alterations in muscle-specific *Bmal1*^*KO*^ mice (Dyar et al. [@CR39]; Hodge et al. [@CR62]). However, muscle-specific loss of *Bmal1* resulted in decreased skeletal muscle glucose uptake, glucose oxidation and insulin sensitivity, and coupled with a shift towards more oxidative fibres in the *Soleus* muscle (Dyar et al. [@CR38]). Furthermore, recent data show that similar to global *Bmal1*^*KO*^ mice, muscle-specific loss of *Bmal1* leads to significant changes in bone and cartilage throughout the body, thus implicating the role for skeletal muscle clocks in systemic regulation of peripheral clocks beyond muscle (Schroder et al. [@CR135]). All together, these data indicate a critical role for intrinsic skeletal muscle clocks in regulating local skeletal muscle maintenance during ageing as well as systemic metabolic health.

Circadian rhythms in skeletal muscle responses to exercise {#Sec18}
----------------------------------------------------------

Recent studies have demonstrated that the molecular clock in skeletal muscle can be dissociated from the rhythm of the SCN by restricting time of feeding or exercise cues (Damiola et al. [@CR33]; Schroder and Esser [@CR134]). Zambon et al. ([@CR175]) reported that there is an interaction between time of day and contraction, on the expression of clock genes in human *Quadriceps* muscle after an acute bout of resistance exercise. This suggests that contractile activity might be a zeitgeber for the molecular clock mechanism in skeletal muscle. This was supported by real-time bioluminescence imaging of skeletal muscle tissues from *Per2*::luc luciferase reporter mice following scheduled bouts of either voluntary or involuntary endurance exercise, which showed phase-shifted rhythms in skeletal muscle tissues, but not in the SCN (Wolff and Esser [@CR172]). In addition, voluntary wheel running in arrhythmic clock mutant mice was able to partially rescue the metabolic phenotype of the skeletal muscle (Pastore and Hood [@CR117]). Given that the prognosis of many age-related diseases is strongly linked to the skeletal muscle function (Kadar et al. [@CR70]), these findings illustrate the potential impact of physical activity as an entrainment cue for skeletal muscle clocks.

The time of day has long been known to be important regarding skeletal muscle performances. In humans, more than 20 studies have shown that skeletal muscle torque, strength and power is higher in the late afternoon, between 16:00 and 18:00 h, compared to the morning (Sedliak et al. [@CR137]; Zhang et al. [@CR176]). In addition, a recent study in humans has demonstrated that the individual chronotype is an important parameter in the time of optimal performance (Facer-Childs and Brandstaetter [@CR45]). This concept points out the importance of chronobiology in skeletal muscle activity. Another recent study has reported the influence of daytime scheduled exercise on the expression of genes in schedule-trained horses (McGivney et al. [@CR103]). Interestingly, the peak of the clock-regulated protein UCP3 (Uncoupling Protein 3) preceded the scheduled time of exercise, indicative of an anticipated antioxidant response to ROS during exercise (Murphy et al. [@CR107]). This suggests that the controlled timing of exercise-induced ROS and oxidative damage in tissues with synchronised clock may facilitate downstream redox signalling and repair pathways post-exercise, thus modulating muscle adaptive responses. Indeed, exercising at the 'right' time is not only essential for optimal improvement of skeletal muscle performance but also to simultaneously limit damage. In addition to established endogenous sources of DNA damage, night shift work/activity, known to disrupt circadian rhythms in humans, has recently been classified by WHO as a probable carcinogen (class 2a) (Stevens and Zhu [@CR151]).

Circadian regulation of redox-sensitive pathways and implications for skeletal muscle homoeostasis {#Sec19}
--------------------------------------------------------------------------------------------------

Recent studies have demonstrated oscillations in several redox processes including levels of NADP/NADPH (Stringari et al. [@CR152]; Zhou et al. [@CR180]), protein glutathionylation, FAD/NADPH, protein carbonylation and total GSH (Desvergne et al. [@CR35]; Pekovic-Vaughan et al. [@CR120]) as well as oxidation state of peroxiredoxin (Prx) proteins (Edgar et al. [@CR40]; O'Neill and Reddy [@CR113]) and cytosolic release of mitochondrial H~2~O~2~ production (Kil et al. [@CR73]). Consistent with these findings, a wide array of genes involved in the antioxidant response exhibits diurnal oscillations in different species (Beaver et al. [@CR7]; Lai et al. [@CR81]). Moreover, clock mutant mouse models exhibit several ROS-associated phenotypes (Geyfman et al. [@CR49]; Lee et al. [@CR86]; Musiek et al. [@CR108]; Pekovic-Vaughan et al. [@CR120]). Most pronounced is the premature ageing phenotype and shortened lifespan of *Bmal1*^*KO*^ mice, which can be partially rescued by life-long administration of the glutathione (GSH) precursor, *N*-acetyl cysteine (NAC) (Kondratov et al. [@CR76], [@CR77]). *Bmal1*^*KO*^ mice exhibit high ROS levels and stress-induced premature senescence (Khapre et al. [@CR72]; Lee et al. [@CR86]). We have recently demonstrated that circadian regulation of antioxidant transcription factor NRF2 is required for rhythmic GSH-based antioxidant protection of tissues to oxidative injury through transcriptional regulation of genes involved in the rate-limiting production and utilisation of GSH (Pekovic-Vaughan et al. [@CR120]). Consistent with these findings, *Clock*^*Δ19*^ mutant mice demonstrate decreased levels and activity of NRF2 and total GSH together with increased protein carbonylation, a marker of oxidative protein load (Pekovic-Vaughan et al. [@CR120]). Circadian oscillations of Prx oxidation (Edgar et al. [@CR40]; O'Neill and Reddy [@CR113]), cytosolic H~2~O~2~ and GSH/GSSG ratio (Radha et al. [@CR127]), however, can occur in the absence of transcriptional cycles (Putker and O'Neill [@CR124]), implicating a role for both transcriptional and transcription-independent mechanisms of circadian redox control (Patel et al. [@CR118]). This suggests that the oxidation status of many other important redox-regulated protein thiols might oscillate and thus influence the downstream redox relay signalling pathways. Future research is needed to determine the redox mechanisms of molecular clock function in skeletal muscle, identify the redox relay pathways regulated by the molecular clock and their role in skeletal muscle adaptive responses to exercise and ageing.

Conclusions {#Sec20}
===========

The endogenous redox signals generated by contracting skeletal muscle can activate a number of transcription factors with subsequent effects on gene expression and activation of specific cellular pathways. In young adults, adaptation and rebuilding of skeletal muscle fibres occurs in response to exercise, whilst muscles of older adults have a blunted response to exercise, often associated with dampened or chronic activation of specific transcription factors. The long-term effects of altered cellular signalling and an inability to efficiently rebuild and repair muscle fibres manifests physiologically as a decrease in the number of fibres and atrophy of the remaining fibres. Key transcription factors associated with exercise are regulated by the circadian clock and correct timing of activities could maximise the beneficial effects of exercise, although the circadian clock itself can dampen and/or phase shift during ageing (Yamazaki et al. [@CR173]). Moreover, novel epigenetic regulators, such as miRNAs, add a new layer of redox balance regulation through controlling the expression and activity of transcription factors and enzymes associated with redox signalling. As a better understanding of the canonical mechanisms associated with muscle wasting during ageing is beginning to emerge, and considering the challenges of targeting disrupted redox homoeostasis by antioxidant interventions, novel strategies, such as circadian and microRNA regulation of redox signalling, may be better poised at improving loss of muscle mass and function during ageing.

In skeletal muscle, synchronisation of exercise with circadian clock would ensure optimal activation of signalling pathways for maintaining muscle mass and function (Wolff and Esser [@CR172]). Mimicking the gene expression profile induced as a result of exercise or pharmaceutically through genetic manipulation has also been proposed as a potential therapeutic approach against sarcopenia. Manipulation of miRNA expression represents a potentially powerful therapeutic approach for treating muscle disorders including sarcopenia. Cholesterol-modified microRNA mimics and antagomiRs show efficient delivery in vivo not associated with toxicity (Krutzfeldt et al. [@CR78]). Moreover, miRNA-based therapeutics against liver cancer are currently in clinical trials (<http://www.mirnarx.com/pipeline/mirna-MRX34.html>). Despite emerging data demonstrating the involvement of miRNAs in regulating skeletal muscle and satellite cell function (Cheung et al. [@CR27]; Soriano-Arroquia et al. [@CR145], [@CR146]), it remains to be established which miRNAs play the key role in regulating sarcopenia development and which may act as a compensatory mechanism. A clue may exist in studies investigating changes in miRNA expression following exercise although, future studies will need to focus on defining the signatures of human sarcopenia and characterising the miRNA:target interactions in muscles in vivo during ageing. Therefore effective miRNA delivery strategies, combined with appropriate circadian delivery time and as well as scheduled exercise interventions based on the chronobiology of skeletal muscle, constitute novel therapeutic approaches for the treatment of age-related muscle wasting and thus warrant further investigation.
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